Neuroendovascular Coil Market Report 2026

Neuroendovascular Coil Market Overview

• Neuroendovascular Coil market size has reached to $1.39 billion in 2025 • Expected to grow to $1.96 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: Rising Prevalence Of Neurovascular Diseases Fuels Expansion Of The Neuroendovascular Coil Market • Market Trend: Penumbra Launches Advanced Shape-Configured Coil for Targeted Neurovascular Procedures • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neuroendovascular Coil Market?

A neuroendovascular coil is a thin wire inserted into blood vessels to block off or divert blood flow from the affected area, promoting clotting and preventing further complications. It is a medical device for treating cerebral aneurysms and other vascular abnormalities. The main product types of neuroendovascular coils are guglielmi detachable coils (GDCs) and matrix coils. Guglielmi detachable coils (GDCs) are medical devices used in endovascular procedures to treat cerebral aneurysms by filling them with detachable platinum coils to promote clotting and prevent rupture. Various types of indications include ruptured aneurysms and unruptured aneurysms. It is used for several applications, such as tumor surgery and medical teaching, by various end users, including hospitals, ambulatory surgical centers (ASCs), stroke centers, and others.

What Is The Neuroendovascular Coil Market Growth Forecast?

The neuroendovascular coil market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing adoption of next-generation embolization devices, rising investments in neurovascular research, expansion of minimally invasive treatment options, growing demand for safer aneurysm management, increasing focus on personalized neurointerventional care. Major trends in the forecast period include increasing adoption of advanced detachable coil designs, rising use of flow-diverter and matrix coils, growing demand for minimally invasive neurovascular procedures, expansion of high-precision coil deployment techniques, enhanced focus on long-term treatment outcomes.

Global Neuroendovascular Coil Market Segmentation

1) By Product Type: Guglielmi Detachable Coils (GDCs), Matrix Coils 2) By Indication: Ruptured Aneurysm, Unruptured Aneurysm 3) By Application: Medical Teaching, Cerebral Aneurysm Treatment, Other Vascular Abnormalities 4) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Stroke Centers, Other End Users Subsegments: 1) By Guglielmi Detachable Coils (GDCs): Soft GDCs, Standard GDCs, Detachable GDCs With Various Configurations 2) By Matrix Coils: Soft Matrix Coils, Coated Matrix Coils, Detachable Matrix Coils, Flow Diverter Matrix Coils

What Are The Drivers Of The Neuroendovascular Coil Market?

The growing prevalence of neurovascular diseases is expected to propel the growth of the neuroendovascular coil market going forward. Neurovascular diseases affect the blood vessels supplying the nervous system, often leading to neurological symptoms and complications. The rising prevalence of neurovascular diseases is driven by an aging population, as older adults are more susceptible to conditions such as stroke and aneurysms, increasing the overall disease burden. Neuroendovascular coils are used in treating neurovascular diseases by being inserted into blood vessels to block off or stabilize abnormal blood vessel structures, reducing the risk of bleeding or other complications. For instance, in in March 2025, according to a report published by the Stroke Association, a UK-based charity for stroke support, in 2024, the UK had 1.3 million stroke survivors, a number expected to increase to 2.1 million by 2035. Therefore, the growing prevalence of neurovascular diseases is driving the growth of the neuroendovascular coil industry. The growing healthcare expenditure is expected to propel the growth of the neuroendovascular coil market going forward. Healthcare expenditure refers to the amount of money spent on healthcare services, including medical goods and services, public health activities, and administration. Growing healthcare expenditure is driven by factors such as an aging population, advancements in medical technology, rising costs of pharmaceuticals, and increased prevalence of chronic diseases. The escalating healthcare expenditure contributes to advancements in neuroendovascular coil technology, fostering innovation, and accessibility, and improving patient outcomes in the treatment of cerebral aneurysms and vascular disorders. For instance, in June 2024, according to Health Affairs, a US-based academic journal, the national healthcare expenditure in the U.S. is expected to rise from $4,799.3 billion in 2023 to $5,048.8 billion in 2024, indicating an increase of about $249.5 billion. Therefore, the rise in healthcare expenditures is driving the growth of the neuroendovascular coil industry.

Key Players In The Global Neuroendovascular Coil Market

Major companies operating in the neuroendovascular coil market are Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Kaneka Neurovascular USA, W.L. Gore & Associates Inc., Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., MicroVention Inc., Medikit Co. Ltd., Balt USA LLC, Acandis GmbH, Rapid Medical Ltd., Shape Memory Medical Inc., Wuhan HNC Technology Co. Ltd., Intratech Medical Inc., Phenox GmbH, Cerenovus, Svelte Medical Systems

Global Neuroendovascular Coil Market Trends and Insights

Major companies operating in the neuroendovascular coil market are focusing on technological innovation, such as shape-configured, adaptive embolization coils, which enable precise vessel wall apposition, controlled deployment, and dense occlusion in small and complex neurovascular structures. Shape-configured, adaptive embolization coils use specialized coil geometry and anchoring capabilities to conform to vessel anatomy, optimize occlusion, and support sequential filling with complementary coils, improving procedural accuracy and stability in the treatment of intracranial aneurysms and other neurovascular abnormalities. For instance, in October2025, Penumbra, a US-based neurovascular medical device company, launched the SwiftSET Neuro Embolization Coil. The coil features a.135 primary diameter, shape-optimized configuration for vessel wall apposition, and anchoring design that allows physicians to set an initial anchor and fill with space-seeking SwiftPAC coils, providing precise, controllable, and secure embolization in small or tortuous vessels.

Regional Outlook

North America was the largest region in the neuroendovascular coil market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Neuroendovascular Coil Market?

The neuroendovascular coil market consists of sales of push able coils, framed coils, complex-shaped coils, micro coils, macro coils, guidewires (used in conjunction with coils), and catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.